Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Sunanda, Kane"'
Autor:
Maaz B. Badshah, Saqib Walayat, Umair Ahmed, Sonu Dhillon, Sherri Yong, Sunanda Kane, Shoba Thievanayagam
Publikováno v:
Journal of Medical Case Reports, Vol 11, Iss 1, Pp 1-4 (2017)
Abstract Background Orofacial granulomatosis is a relatively recent term coined by Wiesenfield et al. in 1985 to define granulomatous lesions of oral mucosa without intestinal involvement. When it presents in a triad encompassing facial nerve palsy,
Externí odkaz:
https://doaj.org/article/dc755170459c4c47a66c3e4d673d5704
Autor:
Abigail J. Meyers, Sunanda Kane
Publikováno v:
Pediatric Inflammatory Bowel Disease ISBN: 9783031147432
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b75744b09a6911d38410e06fcfca6ee8
https://doi.org/10.1007/978-3-031-14744-9_53
https://doi.org/10.1007/978-3-031-14744-9_53
Publikováno v:
Gastroenterology.
Publikováno v:
Gastroenterology.
Autor:
Kim, Isaacs, Sunanda, Kane
Publikováno v:
Gastroenterology Research
Background There is paucity of head-to-head studies comparing the effectiveness of ustekinumab (UST) and adalimumab (ADA) in Crohn’s disease (CD). Here we provide a real-world comparison of these two agents. Methods We conducted an ambidirectional
Autor:
Sunanda Kane
Publikováno v:
Alimentary pharmacologytherapeuticsREFERENCES. 56(5)
Publikováno v:
American Journal of Gastroenterology. 117:e1789-e1790
Publikováno v:
American Journal of Gastroenterology. 117:e559-e560
Autor:
Thomas W Fredrick, Guilherme P Ramos, Manuel B Braga Neto, Sunanda Kane, William A Faubion, Edward V Loftus, Darrell S Pardi, Shabana F Pasha, Francis A Farraye, Lizhi Zhang, Laura E Raffals
Publikováno v:
Crohn's & Colitis 360. 4
Background Microscopic colitis (MC) is suspected to result from increased immune activity in gut mucosa. Immune checkpoint inhibitors (ICIs) treat cancer by activating the immune system, and further investigation is needed regarding their role in the
Autor:
Amanda M. Johnson, Maria Barsky, Waseem Ahmed, Samantha Zullow, Jonathan Galati, Vipul Jairath, Neeraj Narula, Farhad Peerani, Benjamin H. Click, Elliot S. Coburn, ThucNhi Tran Dang, Stephanie Gold, Manasi Agrawal, Rajat Garg, Manik Aggarwal, Danah Mohammad, Brendan Halloran, Gursimran S. Kochhar, Hannah Todorowski, Nabeeha Mohy Ud Din, James Izanec, Amanda Teeple, Chris Gasink, Erik Muser, Zhijie Ding, Arun Swaminath, Komal Lakhani, Dan Hogan, Samit Datta, Ryan C. Ungaro, Brigid S. Boland, Matthew Bohm, Monika Fischer, Sashidhar Sagi, Anita Afzali, Thomas Ullman, Garrett Lawlor, Daniel C. Baumgart, Shannon Chang, David Hudesman, Dana Lukin, Ellen J. Scherl, Jean-Frederic Colombel, Bruce E. Sands, Corey A. Siegel, Miguel Regueiro, William J. Sandborn, David Bruining, Sunanda Kane, Edward V. Loftus, Parambir S. Dulai
Publikováno v:
The American journal of gastroenterology.
We evaluated the real-world effectiveness and safety of ustekinumab (UST) in patients with Crohn's disease (CD).This study used a retrospective, multicenter, multinational consortium of UST-treated CD patients. Data included patient demographics, dis